Literature DB >> 22964455

Endogenous sterol biosynthesis is important for mitochondrial function and cell morphology in procyclic forms of Trypanosoma brucei.

Guiomar Pérez-Moreno1, Marco Sealey-Cardona, Carlos Rodrigues-Poveda, Michael H Gelb, Luis Miguel Ruiz-Pérez, Víctor Castillo-Acosta, Julio A Urbina, Dolores González-Pacanowska.   

Abstract

Sterol biosynthesis inhibitors are promising entities for the treatment of trypanosomal diseases. Insect forms of Trypanosoma brucei, the causative agent of sleeping sickness, synthesize ergosterol and other 24-alkylated sterols, yet also incorporate cholesterol from the medium. While sterol function has been investigated by pharmacological manipulation of sterol biosynthesis, molecular mechanisms by which endogenous sterols influence cellular processes remain largely unknown in trypanosomes. Here we analyse by RNA interference, the effects of a perturbation of three specific steps of endogenous sterol biosynthesis in order to dissect the role of specific intermediates in proliferation, mitochondrial function and cellular morphology in procyclic cells. A decrease in the levels of squalene synthase and squalene epoxidase resulted in a depletion of cellular sterol intermediates and end products, impaired cell growth and led to aberrant morphologies, DNA fragmentation and a profound modification of mitochondrial structure and function. In contrast, cells deficient in sterol methyl transferase, the enzyme involved in 24-alkylation, exhibited a normal growth phenotype in spite of a complete abolition of the synthesis and content of 24-alkyl sterols. Thus, the data provided indicates that while the depletion of squalene and post-squalene endogenous sterol metabolites results in profound cellular defects, bulk 24-alkyl sterols are not strictly required to support growth in insect forms of T. brucei in vitro.
Copyright © 2012 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964455     DOI: 10.1016/j.ijpara.2012.07.012

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  15 in total

1.  Sterol methyltransferase is required for optimal mitochondrial function and virulence in Leishmania major.

Authors:  Sumit Mukherjee; Wei Xu; Fong-Fu Hsu; Jigesh Patel; Juyang Huang; Kai Zhang
Journal:  Mol Microbiol       Date:  2018-10-21       Impact factor: 3.501

2.  Discovery of an ergosterol-signaling factor that regulates Trypanosoma brucei growth.

Authors:  Brad A Haubrich; Ujjal K Singha; Matthew B Miller; Craigen R Nes; Hosanna Anyatonwu; Laurence Lecordier; Presheet Patkar; David J Leaver; Fernando Villalta; Benoit Vanhollebeke; Minu Chaudhuri; W David Nes
Journal:  J Lipid Res       Date:  2014-11-25       Impact factor: 5.922

Review 3.  Metabolic flexibility in Trypanosoma cruzi amastigotes: implications for persistence and drug sensitivity.

Authors:  Peter C Dumoulin; Barbara A Burleigh
Journal:  Curr Opin Microbiol       Date:  2021-08-26       Impact factor: 7.584

4.  Mitochondrial shape and function in trypanosomes requires the outer membrane protein, TbLOK1.

Authors:  Megan L Povelones; Calvin Tiengwe; Eva Gluenz; Keith Gull; Paul T Englund; Robert E Jensen
Journal:  Mol Microbiol       Date:  2013-01-21       Impact factor: 3.501

5.  Antileishmanial Activity of Ezetimibe: Inhibition of Sterol Biosynthesis, In Vitro Synergy with Azoles, and Efficacy in Experimental Cutaneous Leishmaniasis.

Authors:  Valter Viana Andrade-Neto; Edézio Ferreira Cunha-Júnior; Marilene Marcuzzo do Canto-Cavalheiro; Geórgia Correa Atella; Talita de Almeida Fernandes; Paulo Roberto Ribeiro Costa; Eduardo Caio Torres-Santos
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

6.  Leptomonas seymouri: Adaptations to the Dixenous Life Cycle Analyzed by Genome Sequencing, Transcriptome Profiling and Co-infection with Leishmania donovani.

Authors:  Natalya Kraeva; Anzhelika Butenko; Jana Hlaváčová; Alexei Kostygov; Jitka Myškova; Danyil Grybchuk; Tereza Leštinová; Jan Votýpka; Petr Volf; Fred Opperdoes; Pavel Flegontov; Julius Lukeš; Vyacheslav Yurchenko
Journal:  PLoS Pathog       Date:  2015-08-28       Impact factor: 6.823

7.  Squalene synthase as a target for Chagas disease therapeutics.

Authors:  Na Shang; Qian Li; Tzu-Ping Ko; Hsiu-Chien Chan; Jikun Li; Yingying Zheng; Chun-Hsiang Huang; Feifei Ren; Chun-Chi Chen; Zhen Zhu; Melina Galizzi; Zhu-Hong Li; Carlos A Rodrigues-Poveda; Dolores Gonzalez-Pacanowska; Phercyles Veiga-Santos; Tecia Maria Ulisses de Carvalho; Wanderley de Souza; Julio A Urbina; Andrew H-J Wang; Roberto Docampo; Kai Li; Yi-Liang Liu; Eric Oldfield; Rey-Ting Guo
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

8.  Phylogenomic reconstruction indicates mitochondrial ancestor was an energy parasite.

Authors:  Zhang Wang; Martin Wu
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

Review 9.  Drug strategies targeting CYP51 in neglected tropical diseases.

Authors:  Jun Yong Choi; Larissa M Podust; William R Roush
Journal:  Chem Rev       Date:  2014-10-22       Impact factor: 60.622

Review 10.  The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics.

Authors:  Rubem Figueiredo Sadok Menna-Barreto; Solange Lisboa de Castro
Journal:  Biomed Res Int       Date:  2014-03-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.